We have prepared this document,“Sublingual Immunotherapy: World Allergy Organization
Position Paper 2013 Update”, according to the evidence-based criteria, revising and …

Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom
allergy are well established; however, clinical contraindications to AIT are not always well …

Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a
fifth of the general population. Symptoms of AR can be controlled with allergen avoidance …

Background Asthma is a common long‐term respiratory disease affecting approximately 300
million people worldwide. Approximately half of people with asthma have an important …

Antecedentes: El asma sigue siendo una patología respiratoria crónica frecuente en México.
Se han descrito nuevos métodos para el diagnóstico y tratamiento conforme se renuevan …

Background: Asthma continues to be one of the most frequent chronic respiratory diseases
in our country. New methods for diagnosis and treatment have been described; accordingly …

Background Allergen immunotherapy (AIT) is the only causal therapy for IgE-mediated
allergy. There is less evidence about the safety and efficacy of AIT especially subcutaneous …

Antecedentes: La Sociedad Latinoamericana de Alergia, Asma e Inmunología (SLAAI)
presenta un documento acerca del uso de la inmunoterapia en Latinoamérica en el que se …

Background Allergen immunotherapy is the only treatment that may modify the natural
course of allergic diseases. Sublingual immunotherapy (SLIT) is a promising treatment …

Incidences of allergic disease have recently increased worldwide. Allergen-specific
immunotherapy (SIT) has long been a controversial treatment for allergic diseases. Although …